Relay Therapeutics, Inc. (RLAY)
$17.98+0.56%Close
SELLRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.1B
- Beta
- 1.73
- P/E (TTM)
- -11.94
- Short % float
- 34.34%
- Days to cover
- 12.6
- SI change
- +5.1%
- 1W
- -7.27%
- 1M
- -4.72%
- vs SPY 1W
- -7.69%
- vs SPY 1M
- -6.78%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RLAY?
- LOPJLB’s latest quantitative signal on Relay Therapeutics, Inc. (RLAY) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is RLAY in?
- Relay Therapeutics, Inc. (RLAY) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Relay Therapeutics, Inc. (RLAY) do?
- Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administere…